China reports 13 new COVID-19 cases vs 5 a day earlier

China reported 13 new mainland COVID-19 cases on May 6, up from five cases a day earlier, the country's national health authority said on Friday.

The National Health Commission said in a statement all of the new cases were imported infections originating from overseas. The number of new asymptomatic cases, which China does not classify as confirmed cases, rose to 17 from 7 cases a day earlier.

The total number of confirmed COVID-19 cases in mainland China now stands at 90,739, while the death toll remained unchanged at 4,636.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China administered total of 308.23 mln doses of COVID-19 vaccines as of May 7China carried out about 10.5 million vaccinations against COVID-19 on May 7, bringing the total number administered to 308.23 million, according to data released by the National Health Commission on Saturday.
Read more »

China administered total of 317.59 mln doses of COVID-19 vaccines as of May 8China carried out about 9.36 million vaccinations against COVID-19 on Saturday, bringing the total number administered to 317.59 million, according to data released by the National Health Commission.
Read more »

China administered total of 332.96 mln doses of COVID-19 vaccines as of May 10China carried out about 8.7 million vaccinations against COVID-19 on May 10, bringing the total number of doses administered to 332.96 million, according to data released by the National Health Commission on Tuesday.
Read more »

China reveals multiple double mutant COVID cases in countryThree businessmen returning from India via Nepal tested positive on arrival in southwest China last month, according to a field note published in 'China CDC Weekly.'
Read more »

U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotechThe Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to aid poor countries will not hand sensitive U.S. biopharmaceutical technology to China and Russia, responding to a chorus of concerns, U.S. and industry officials say.
Read more »